You are visiting a website that is not intended for your region

The page or information you have requested is intended for an audience outside the United States. By continuing to browse you confirm that you are a non-US resident requesting access to this page or information.

Switch to the US site

COVID-19 Resource Center

Healthcare professionals can find help and guidance on how to benefit from our offerings to treat your patients, as well as other practical information and advice.

Read more

News

Change in number of shares and votes in Getinge

September 29, 2017 Gothenburg, Sweden

Change in number of shares and votes in Getinge

Getinge AB (“Getinge”) has, as previously announced, carried out a rights issue of class A and B shares. The issue of shares has resulted in changes in the number of shares and votes in Getinge as follows:

Prior to the issuance of new shares, there were in total 238,323,377 shares in Getinge, of which 15,940,050 class A shares, corresponding to 159,400,500 votes, and 222,383,327 class B shares, corresponding to 222,383,327 votes, 381,783,827 votes in total.

The number of shares has through the issuance of new shares increased by 34,046,196. The number of votes has increased by 54,540,546. As of September 29, 2017, there are in total 272,369,573 shares in Getinge, of which 18,217,200 class A shares, corresponding to 182,172,000 votes, and 254,152,373 class B shares, corresponding to 254,152,373 votes, 436,324,373 votes in total.

For further information, please contact
Lars Mattsson, Head of Investor Relations
Phone: +46(0)10 335 00 43
E-mail: lars.mattsson@getinge.com 

Getinge discloses the information herein pursuant to Chapter 4, Section 9 of the Swedish Financial Instruments Trading Act. The information was submitted for publication on September 29, 2017 at 10.00 CET.

About Getinge
Getinge is a global provider of innovative solutions for operating rooms, intensive-care units, sterilization departments and for life science companies and institutions. Based on our first-hand experience and close partnerships with clinical experts, healthcare professionals and medtech specialists, we are improving everyday life for people, today and tomorrow. 

Files

Share: